MedTrace Logo

Transcutaneous Spinal Stimulation for Children and Youth With Spina Bifida

NCT06918119 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-10-14

No results posted yet for this study

Summary

A study to use transcutaneous spinal cord stimulation to characterize sensorimotor deficits in a pediatric population of individuals with spina bifida.

Conditions

  • Myelomeningocele
  • Spina Bifida

Interventions

DEVICE

Transcutaneous stimulation

DS8R (Digitimer LLC) for transcutaneous neurostimulation.

Sponsors & Collaborators

Principal Investigators

  • Kristin Zhao, Ph.D. · Mayo Clinic

  • Joline Brandenburg, M.D. · Mayo Clinic

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
5 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-07
Primary Completion
2028-07-31
Completion
2030-07-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06918119 on ClinicalTrials.gov